Last edition
News about "Gobivaz, First Simponi Biosimilar, Wins EEA Approv"
Gobivaz, First Simponi Biosimilar, Wins EEA Approval
Alvotech, a global biotechnology company focused on biosimilars, and Advanz Pharma, a UK-based pharmaceutical company specializing in specialty and hospital medicines, announced that the European Commission has granted marketing authorizations for Gobivaz, Alvotech’s biosimilar to Simponi (golimumab).
Gobivaz, First Simponi Biosimilar, Wins EEA Approv | 23/11/2025 | By Darshana | 100
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members